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ABSTRACT 
 
 
South Florida has had the largest number of U.S. Zika infection cases during the recent outbreak. 
This study aimed at assessing South Floridians’ basic knowledge, perceptions of the seriousness 
and susceptibility to Zika infection, their information sources and needs, as well as their attitudes 
towards the protective measures proposed by the CDC. We also wanted to assess whether any of 
those factors have affected the frequency of participants’ undertaking of the protective behaviors. 
To this end, we designed an online questionnaire and surveyed the responses of five hundred 
South Floridians (Age=18-78 years). We found significant gaps in participants’ knowledge about 
the risk groups, routes of transmission, treatment, and complications of Zika infection. Older age 
and college education were associated with significantly higher knowledge scores, while the 
presence of pregnant women in the household was associated with lower scores. About half of 
the participants perceived Zika to be a profoundly severe health problem, but less than one-third 
believed that their susceptibility to the infection is high. 
Most participants agreed that undertaking the measures that limit exposure to mosquito bites 
would be effective in preventing infections and that they would be able to carry-out these 
measures if recommended by the CDC, but a significantly lower proportion had similar 
responses to the items regarding protection against sexual transmission.  
There was a significant association between the frequency of protective behavior undertaking 
and respondents’ beliefs about the seriousness and personal susceptibility to the infection, as well 
as their beliefs regarding the efficacy of the protective behaviors.  
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Finally, most participants reported media platforms as their sources of information about Zika, 
while a minority of them received their information directly from healthcare professionals.  
These findings suggest that more targeted risk communication efforts are needed to increase 
South Floridians’ awareness about Zika’s public health threat. 
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INTRODUCTION  
Biology 
 
Zika virus (ZIKV) is an arbovirus that belongs to the genus Flavivirus of the family Flaviviridae 
[1]. Other members of this genus include the Yellow fever, Dengue, Chikungunya and West Nile 
viruses[2] . 
Cryo-microscopic analysis showed that although Zika shares a similar overall structure to that of 
other Flaviviruses, it exhibits some differences that might explain its specific cellular tropism 
and unique ability to survive in the acrid conditions of various body fluids for long periods of 
time [3]. For instance, the different amino acid sequence surrounding the glycosylation site of 
Asn154 in the envelope protein of ZIKV when compared to other Flaviviruses could influence its 
predilection for targeting neural progenitor cells [4]. Moreover, Cryo-EM showed that ZIKV 
possesses a more compact surface and is more thermally stable than other Flaviviruses[3].. 
However, a recent research reported that, under physiological conditions, ZIKV has not been 
found to be uniquely heat stable in comparison to other Flaviviruses, thereby putting the 
previously proposed pathobiological mechanism into question[5]. 
ZIKV is a Positive-sense single-stranded RNA virus [6]. Its 10,794 nucleotides-long genome 
contains regions that encode a single polypeptide of about 3419 amino acids flanked by 5’ and 3’ 
UTRs[7]. The single polypeptide is cleaved by viral and host proteases to produce three 
structural proteins (Envelope [E], Core [C], Precursor of membrane [prM]) and seven non-
structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5)[8].The non-structural 
proteins play important roles in viral assembly and replication, as well as in circumventing the 
immune response of the host[9]. 
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Following binding of viral E protein to surface receptors of the host cell, the Virion gains entry 
into the host cell through receptor-mediated endocytosis[10]. The low pH inside the endosome 
triggers a conformational change in the viral surface proteins, with subsequent fusion of viral and 
endosomal membranes[10]. Viral genome is then released into the host cell cytoplasm, and is 
translated at the surface of the ER[10]. The immature Virion assembles at the ER, and then is 
transported to the Golgi apparatus. Finally, Virion maturation takes place at the trans-Golgi 
apparatus when the prM protein is proteolytically modified, and the mature viral particle is 
released by exocytosis [10]. 
Phylogenetic analysis showed that ZIKV strains can be divided into two lineages: Asian and 
African[11] . The strains isolated during the recent outbreak belong to the Asian lineage [12]. 
The African lineage was found in cell culture studies to be more virulent and to cause higher 
rates of early cell death than the Asian counterpart[13]. This milder inflammatory response might 
provide an explanation for the ability of the Asian lineage strains to cause persistent infections of 
fetal neural progenitor cells following trans-placental infection[14]. 
 
Routes of Transmission 
 
The virus is mainly transmitted to humans through the bite of the mosquito species: A. aegypti 
and A. albopticus . These mosquitoes are also the vectors transmitting other flavivirus infections, 
such as Dengue and yellow fever [15]. ZIKV has also been isolated from other Mosquito species, 
but their competence as vectors for transmission to humans is yet to be confirmed [16]. In 
addition to the vector-borne infection, human to human transmission can also occur. Sexual 
transmission is a well-recognized route of ZIKV transmission[17, 18]. The virus is shed in 
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vaginal secretions and in semen, where it can be detected for several months after the acute 
infection [19]. It’s also secreted in other body fluids, but there isn’t sufficient evidence 
supporting transmission via those routes, except for transmission through infected blood[20, 21]. 
Also, the virus can be transmitted from a pregnant woman to her fetus either trans-placentally or 
through contact with vaginal secretions during delivery[22, 23].  
 
Diagnosis & Screening 
 
Viral RNA can be detected in patients’ serum for about seven days after the onset of symptoms 
using RT-PCR [24]. The same technique can be used to detect viral particles in other body fluids, 
such as urine and semen, where they can be detectable for longer periods than in serum samples 
[25, 26]. Another possible approach to the diagnosis is by using ELISA kits that detect 
antibodies against viral proteins. IgM levels can be detectable in serum for up to twelve weeks 
following the onset of symptoms, and IgG levels can be detected as early as two weeks after the 
fever onset[24]. While this method is quick and easy, due to the cross-reactivity of those 
antibodies with other Flaviviruses, a positive test must be confirmed using plaque reduction 
neutralization test [27]. 
The CDC recommends screening for all pregnant women with possible exposure to ZIKV 
regardless of the presence of symptoms, and to all symptomatic patients with possible exposure 
[28]. 
Treatment 
 
There has been a lot of research over the past two years aiming at finding potential therapeutics 
for Zika infections. Most of these projects utilized compounds that were previously approved for 
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other purposes, and some of these drugs showed good efficacy in vitro and in animal studies[29, 
30]. However, as of now, there is no approved specific treatment for Zika infection, and 
treatment is symptomatic. Acetaminophen can be used to ameliorate the fever and pain in 
symptomatic patients[31]. But Aspirin, Ibuprofen, and other NSAIDs should be avoided in 
suspected cases of Zika infection. This is because their use in other Flavivirus infections has 
been associated with hemorrhagic syndromes [32]. 
 
Complications 
 
Congenital Infection 
 
Zika infection during pregnancy can be detrimental to the developing fetus, particularly if the 
infection is acquired during the first trimester, the period of Organogenesis. The system that is 
most commonly reported to be affected in congenital Zika infections is the nervous system. 
ZIKV is neurotropic, with preference for targeting neural progenitor cells [33]. This damage 
might be attributed to the hyper-activation of TLR 3-mediated immune response, which is known 
to be a negative regulator of neural progenitor cells’ growth [34]. Also, Some Bioinformatics 
data suggested a similar role for Retinoic acid response elements [35]. The resulting defective 
brain development can manifest clinically as Microcephaly, defined as a head circumference 
that’s less than two standard deviations below the mean for age, sex, and race [36]. Also, there 
have been case reports of other neurological manifestations of congenital Zika infection, such as: 
vision and hearing impairment, abnormal muscle tone and exaggerated reflexes [37, 38]. In 
addition, congenital Zika infection has been associated with intra-uterine growth restriction 
(IUGR), pulmonary hypoplasia, and stillbirths [39] . While it is still early to assess the full 
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spectrum of long-term complications of congenital Zika infection in humans, experimental 
animal studies indicate that the virus can cause testicular damage, which subsequent impaired 
fertility in males [40]. 
 
Guillain-Barré Syndrome (GBS) 
 
Another complication that might follow Zika infection in any age group is GBS [41]. It is an 
autoimmune disease in which antibodies attack the myelin sheaths of peripheral nerves [42]. 
Clinically, patients present with rapidly progressive ascending muscle weakness and diminished 
deep tendon reflexes [42]. The most dreadful manifestation of GBS is paralysis of the 
Diaphragm, which requires management with mechanical ventilation in the intensive care unit 
[43]. 
 
Prevention 
 
Several Zika vaccines that have been developed over the past few years showed promising 
results in animal studies, and some of them are in the clinical trials phases [44]. These vaccines 
were generated using methods similar to the previously used techniques for developing vaccines 
against other Flaviviruses. Vaccine candidates that are in clinical trials include: a live-attenuated 
vaccine, a DNA-based vaccine, A purified inactivated viral vaccine, mRNA based and viral 
vector-based vaccines [45]. Until such vaccines become approved for human use, prevention is 
based on vector control, limiting exposure to mosquito bites, safe sexual practices, and screening 
of donated blood before use [46]. 
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History  
 
The virus was named after the Ugandian forest in which it was isolated in 1947 from the serum 
of Rhesus monkeys [47]. A year later, the mosquito species (A. africanus) was identified as a 
vector for transmission [47]. 
Antibodies against ZIKV were found in serum samples from residents of several countries in 
equatorial Africa in the following decades [48-50]. However, only mild febrile illnesses were 
reported in those patients, and none of the infected individuals required hospitalization[51]. 
In the late 1960s, the virus was isolated from the mosquito species A.aegypti in tropical Asian 
regions [52]. 
The first major documented Zika outbreak occurred in 2007, when an estimated 73% of the 
population of the Pacific Yap islands in the Federated States of Micronesia were infected [53]. 
The reason that such an outbreak occurred in the Pacific instead of Asia or Africa might be 
because the regular exposure to the infection in endemic regions has prevented outbreaks [51] . 
Also, since the clinical presentation of Zika infection is similar to that of other Flavivirus 
infections, which are endemic in equatorial Africa and Asia, Zika outbreaks in these regions 
might have been misdiagnosed as Dengue or Chikungunya infections [51]. 
In 2013, the second major outbreak occurred in French Polynesia, during which 49% of its 
population were infected [54]. A 20-fold increase in the incidence of GBS was documented in 
French Polynesia at the same period, and two cases of perinatal transmission were also reported 
during this outbreak [22, 55]. 
 Over the following two years, multiple small-scale outbreaks were documented in other Pacific 
islands [56]. 
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The Recent Outbreak 
 
In the Americas 
 
The recent outbreak started in Brazil early on 2015, and then spread to other countries in the 
Americas [57-59]. By the end of 2015, Brazilian health authorities estimated that between 
400,000 and 1,300,000 infection cases occurred in the country [60].  
The outbreak was associated with a great increase in the incidence of Microcephaly and GBS in 
the affected regions, which led the WHO on Feb-2016 to declare Zika as a Public Health 
Emergency of International Concern [41, 61, 62]. 
WHO’s advisory report recommendations included delaying travel to areas with active virus 
transmission , and safe sexual practices or sexual abstinence for pregnant women who live in 
these regions [62]. The director-general of the WHO declared on November 2016 the end of the 
Public Health Emergency of International Concern; emphasizing that Zika infection and its 
complications remain a significant health challenge that needs a long-term program of work [63]. 
 In the United States 
 
Between 2015 and (January 10, 2018), 5,635 symptomatic ZIKV infection cases were recorded 
in the U.S., and another 37,123 were recorded in U.S. territories [64]. Most cases in the U.S. 
were travel related, while the majority of cases in U.S. territories were locally acquired [64]. 
Among the confirmed infection cases were about 7,000 in pregnant women [65]. Zika-associated 
birth defects were observed in about 10% of pregnancies with laboratory-confirmed infections 
[64, 66]. 
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In Florida 
 
96% of the local mosquito-borne Zika infections in the U.S. were in Florida [64]. Four regions in 
the state’s south had active local transmission in 2016, and Miami-Dade County was designated 
as a Zika cautionary travel region until June 2, 2017 [67, 68]. 
Recent research indicated that the virus was probably introduced to South Florida via travelers 
from the Caribbean [69]. The high incidence rate in Miami-Dade might be attributed to the local 
abundance of A.aegypti in the county, combined with the fact that Florida received more visitors 
from Zika endemic regions than any other state in the past few years [69]. 
 
Because of the unavailability of protective vaccines against Zika so far, the public health strategy 
in the United States has been to fund research aimed at developing vaccinations and to initiate 
aggressive vector control campaigns, in addition to targeted risk communication[70]. 
According to the UNICEF’s guidelines, Zika risk communication and community engagement 
campaigns should be based on research assessing public risk perceptions and attitudes towards 
the protective behaviors[71]. The guidelines also recommend that the communication be tailored 
to the specific needs of different population groups[71]. The aim of this research was to assess 
the basic knowledge and risk perceptions regarding the recent Zika outbreak in a sample of 
South Florida residents, their information sources and needs, as well as their beliefs about the 
efficacy of the proposed protective measures. We also wanted to assess which of these factors, if 
any, have affected participants’ undertaking of the protective behaviors.  
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METHODS 
 
Survey Design and Administration 
 
The initial questionnaire was adapted from two previously published survey design guides [72, 
73]. Then, the questions were sent to 25 UCF faculty members and graduate students for 
feedback and modified accordingly. An online survey (Click to access) was subsequently 
designed using Qualtrics platform. After obtaining UCF’s IRB approval (APPENDIX C: UCF 
IRB LETTER), links to the survey were sent to 160 UCF students through emails for pilot 
testing. Next, we started recruiting respondents through Qualtrics Panel Services team. 500 
participants from South Florida who were at least 18 years old were recruited. The amount of 
time spent answering the questions was used as a quality control measure, and respondents who 
completed the survey in less than 1/3 the average time for completion of other participants were 
excluded. Also, a quota was used to get responses with an equal Male: Female distribution. The 
recruitment was done in the period between (8/30/2017) and (9/20/2017). 
 
Survey Items 
 
 The first page is the informed consent page. On this page, a brief description of the aims and 
general structure of the survey is provided, and participants are informed about the procedures 
that will maintain the confidentiality and anonymity of their responses. Then, respondents are 
asked to confirm that they are at least 18 years old and that they agree to participate in the study. 
The next series of questions are about demographics. These include respondents’ age, gender, 
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educational level and residence. In addition, following the suggestions of WHO’s guide, 
questions about the number of women of child-bearing age and the number of pregnant women 
in the household were included in this section. In the following question, respondents are asked 
about the sources of their information about Zika. The (Knowledge) section begins with a 
question assessing participants’ subjective evaluation of the sufficiency of their information 
about Zika. Then, participants’ basic knowledge is assessed with questions about the risk groups, 
routes of transmission, symptoms, treatment, complications of Zika infections, as well as the 
availability of a vaccine against the virus. The next section evaluates respondents’ perception of 
the seriousness of Zika infection on a scale from 1 to 10 (Perception of severity). To provide a 
comparative context, the same question included items for five other diseases, the severity of 
which should be familiar to any adult U.S. citizen. Then, respondents are asked to rate the 
likelihood that they will get infected with Zika if they do not undertake any protective measure 
(Perception of susceptibility). After that, participants are asked about the frequency with which 
they undertook the protective measures against Zika that were proposed by the CDC. A five-
point Likert item format (from NEVER to ALWAYS) was used to assess the frequency of 
undertaking for each of the six protective behaviors. Next, Respondents’ beliefs about the 
effectiveness of those proposed measures (Response efficacy beliefs), and about their ability to 
carry-out those measures (Self-efficacy beliefs) were assessed using Likert items with five-point 
scales (From STRONGLY DISAGREE to STRONGLY AGREE). In the final question, 
respondents are asked about the information that they want to get about Zika. 
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Data Analysis 
 
Intellectus  and SPSS 24 are the softwares that were used for statistical analysis. Tables and 
graphs were designed using Microsoft Excel 2016. 
Knowledge score was calculated as follows: The questions were divided into six groups, and a 
correct answer to each of the groups’ questions was assigned a total score of 1 point. These 
question groups included: Risk groups [Q12] (0.16 point for each correct answer choice), Routes 
of transmission [Q13] (0.11 point for each correct answer choice), Symptoms (Q14), Treatment 
(Q15, Q16) [0.5 point for each question], Complications (Q17, Q18) [0.5 point for each 
question] and Vaccination (Q19). 
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RESULTS 
 
Descriptive Statistics 
 
Demographics 
 
 500 participants from South Florida completed the survey. The female to male ratio was 1:1. 
The age range was between 18-78 years old, and about half of the respondents (49%) were 
between 18-38 years old (Figure 1). About two-thirds of the participants (61%) have a college 
degree, while only 3% haven’t graduated from High School (Figure 2). 58% of those who 
completed the survey reported having at least one woman of child-bearing age living in the 
household, but only 10% of them had pregnant women in their households(Figure 3,Figure 4). 
 
Knowledge Questions 
 
About two-thirds of the participants (61%) thought that they had enough information about Zika. 
However, Objective evaluation revealed significant gaps in their knowledge about the infection. 
For instance, an average of 33% of the respondents did not know that humans, other than 
pregnant women and their babies, can get infected with Zika (Figure 5). Also, while the vast 
majority (96%) correctly identified Mosquito bites as a route of transmission, more than half of 
the participants (56%) did not know that the infection can be sexually transmitted (Figure 6). 
Most participants (79%) recognized that Zika infections are often asymptomatic (Figure 7). In 
terms of treatment,42% of the surveyed mistakenly thought that Antibiotics can treat Zika 
infections, and only 32% knew that Aspirin and other NSAIDs should not be used to treat the 
pain and fever in Zika suspected cases(Figure 8). Microcephaly was recognized as a possible 
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complication of Zika infection during pregnancy by about 90% of the participants, but 34% of 
them didn’t know that the other major complication, Guillain-barré syndrome, can follow Zika 
infection regardless of the age and gender of the infected individual (Figure 9, Figure 10). 
Another significant misconception among the respondents was with regard to vaccination 
availability, with 40% of them mistakenly thinking that there is an FDA-approved vaccine 
against Zika infection (Figure 11).  
Next, we calculated the proportion of respondents who had misconceptions in each of the 
categories of (Knowledge) questions, defined as selecting at least one incorrect answer choice. 
The proportion of participants with misconceptions ranged between 20% and 87%, with more 
than half of them having misconceptions regarding the risk groups, routes of transmission, and 
treatment of Zika infections (Table 1).    
 
Perception of Zika Infection Severity 
 
Of the six diseases we asked about, Zika ranked 3rd in terms of perceived severity, preceded only 
by: Having a Heart attack (1st), and contracting HIV infection (2nd). Zika infection severity rating 
was similar to that of Diabetes. More than half of the participants (55%) thought that getting 
infected with Zika would be a highly serious health problem for them, while only 23% perceived 
the infection to be of low seriousness (Figure 12). 
 
Perception of Personal Susceptibility to Zika Infection 
 
Only 16% of the respondents perceived a high personal likelihood for contracting the infection in 
the following year, and another half (49%) thought that their chances of getting infected with 
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Zika are low, even without undertaking any measures to protect themselves (Figure 13). The 
mean score for the (Perception of susceptibility) question was 4.1/10 (SD= 2.4).  
 
Frequency of Protective Behavior Undertaking 
 
The majority of respondents reported undertaking the Four measures that aim at protecting 
against vector-borne transmission at least sometimes since they learned about the recent Zika 
outbreak. (range = 63% to 79%). A different result, however, was observed for the behaviors that 
target limiting sexual transmission, with more than two-thirds (75% & 70%) of the participants 
reporting that they seldom or never have undertaken those measures (Figure 14). 
 
Response Efficacy Beliefs 
 
With the exception of the (Sexual protection) items, the majority of participants agreed that the 
proposed measures can protect against Zika infection. The proportion of respondents who 
believed that the other four measures can be protective ranged from 66% for the (Wearing long-
sleeved clothes) item to 82% for the item regarding limiting travel to areas with reported active 
transmission (Figure 15).  
 
Self-Efficacy Beliefs 
 
When asked about whether they believe in their ability to carry-out the four measures related to 
limiting exposure to mosquito bites, if the CDC recommended undertaking them, more than 75% 
of the participants answered positively. On the other hand, less than half of them believed in their 
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ability to follow the advice regarding protection against sexual transmission (30.4% & 45%) 
(Figure 16). 
 
Information Sources and Information Needs 
 
Television and Radio were the most reported sources of respondents’ information about Zika, 
while only a minority of them reported getting their information directly from healthcare 
professionals. Interestingly, the group of respondents who received their information directly 
from healthcare professionals included a higher percentage of younger respondents (18-38 years 
of age) than participants from older age groups (Figure 17).  Also, compared to participants with 
other levels of education, a higher proportion of respondents with post-graduate degrees reported 
healthcare professionals as one of their information sources about Zika (Figure 18). There were 
no differences in the distribution of reported information sources between female and male 
participants (Figure 19).    
Finally, with regard to the topics about which participants wanted to learn more information, 
routes of transmission, symptoms, treatment, complications, and prevention of Zika infection 
were all selected with similar frequencies by the participants (Figure 20).  
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Inferential Statistics 
 
Knowledge Scores in Different Demographic Groups 
 
Introduction 
 
To determine if  the age, gender, educational level, the presence of women of child-bearing age 
and of pregnant women in the household were associated with significant differences in 
participants’ knowledge scores, the mean knowledge scores for each category of these 
demographic groups were compared. 
 
Approach 
 
Comparison of the mean knowledge scores among different age groups was made using Analysis 
of Variance (ANOVA), while Independent sample t-tests were used to compare other 
demographic categories. 
 Prior to the analysis, the assumptions of normality and homogeneity of variance were assessed. 
A Shapiro-Wilk test was used to determine whether Knowledge scores followed a normal 
distribution[74]. 
The results of the Shapiro-Wilk test were significant, W = 0.97, p < .001. This suggests that 
knowledge scores are unlikely to have been produced by a normal distribution; thus, normality 
cannot be assumed. However, according to the Central Limit Theorem (CLT), deviations from 
normality will have little effect on the results with a sufficiently large sample size (n > 50) [75]. 
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Levene's test was used to assess whether the homogeneity of variance assumption was met [76]. 
The homogeneity of variance assumption requires the variance to be approximately equal in each 
category of the independent variable groups. The only demographic item in which this 
assumption was violated was the (GENDER) item. For this item, Welch's t-test was used instead 
of the Student's t-test, as the former is more reliable when the two categories of the independent 
variable have unequal distributions [77]. 
 
Results 
 
Age: 
 
The results of the ANOVA were significant, F(2, 497) = 15.35, p < .001, indicating that there 
were significant differences in knowledge scores among the different age groups (Table 2).  
To further examine the differences, t-tests were calculated between each pair of age groups. 
Tukey pairwise comparisons were conducted for all significant effects. The mean of knowledge 
score for the (18-38) age group was significantly smaller than the mean score for the other age 
groups. The means and standard deviations are presented in (Table 3). 
 
Gender: 
 
The result of the independent samples t-test was not significant, t (491.93) = -1.67, p = .095, 
indicating that the null hypothesis cannot be rejected. This suggests that the mean knowledge 
score was not significantly different between female and male participants. (Table 4) presents the 
results of the independent samples t-test.  
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Education Level: 
 
The result of the independent samples t-test was significant, t(498) = -3.19, p = .001, indicating 
that the null hypothesis can be rejected. The mean knowledge score for participants with college 
degrees was significantly higher than the mean for participants with lower educational levels. 
(Table 5) presents the results of the independent samples t-test.  
 
The Presence of Women of Child-Bearing Age in the Household: 
 
The result of the independent samples t-test was not significant, t(498) = 0.52, p = .606, 
indicating that participants’ knowledge scores were not significantly affected by the presence of 
women of child-bearing age in the household. (Table 6) presents the results of the independent 
samples t-test.  
 
The Presence of Pregnant Women in the Household: 
 
The result of the independent samples t-test was significant, t(498) = 3.69, p < .001. The 
presence of pregnant women in the household was associated with a significantly lower mean 
knowledge score. (Table 7) presents the results of the independent samples t-test.  
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Assessing the Association between the Frequency of Protective Behavior Undertaking and 
Participants' Perceptions about the Severity and Personal Susceptibility to Zika Infection 
 
Introduction 
 
To assess whether differences in the reported frequency of protective behavior undertaking were 
associated with differences in respondents’ perceptions of the seriousness and/or of their 
personal susceptibility to Zika infection, the mean scores of the (perception of severity) and 
(Perception of susceptibility) questions were compared between participants who reported 
frequent undertaking of the protective measures and other participants. 
 
Approach 
 
First, Participants were divided into two groups: Those who frequently undertook the protective 
measures (Selected the answer choices OFTEN or ALWAYS), and other respondents. Then, the 
mean scores of the (Perception of Severity & Perception of Susceptibility) questions for the two 
groups were compared using independent samples t-Tests. 
The same methods described in the previous section were utilized for assumption testing and for 
selecting the appropriate analytical approach.  
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Results 
 
The Association between the Frequency of Protective Behavior Undertaking and the Perception 
of Zika Infection Severity: 
 
The result of the independent samples t-test was not significant for any of the six protective 
measures. This indicates that differences in the perception of Zika infection severity among 
participants were not associated with significant differences in the frequency of their protective 
behavior undertaking. (Table 8) summarizes the results of the independent samples t-tests. 
  
The Association between the Frequency of Protective Behavior Undertaking and the Perception 
of Susceptibility to Zika Infection: 
 
 
The results of the independent samples t-test were significant for five of the six protective 
behavior items. In contrast to other Participants, those who reported frequent undertaking of the 
protective measures perceived a significantly higher personal susceptibility to the infection. 
(Table 9) provides a summary of the results. 
  
21 
 
Assessing the Association between the Frequency of Protective Behavior Undertaking and 
Efficacy Beliefs 
 
Introduction 
 
The effect of efficacy beliefs on the adoption of the proposed protective measures was examined. 
Efficacy beliefs included: Response efficacy beliefs, the degree to which the participant believes 
that the proposed behavior can protect from contracting the infection (Q23), and Self-efficacy 
beliefs, respondents’ beliefs about their ability to carry out the proposed measures (Q24).  
Approach 
 
For each of the six proposed protective measures, respondents were divided into two groups 
based on whether they agreed that the behavior in question can be protective against Zika. The 
same method was followed to create another dichotomous variable for the (Self-efficacy) 
question. Then, efficacy beliefs for the group of respondents who reported frequent undertaking 
of the proposed measures were compared to other respondents. This was achieved using Chi-
square tests of association. 
Prior to conducting the analysis, the assumption of adequate cell size was assessed, which 
requires all cells to have expected values greater than zero and 80% of cells to have expected 
values of at least five [78]. For each of the six protective measures, all cells had expected values 
greater than zero, and a total of 100.00% of the cells had expected frequencies of at least five. 
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Results 
 
The Association between the Frequency of Protective Behavior Undertaking and Response 
Efficacy Beliefs: 
 
The results of the Chi-square test were significant in all the items, indicating that the frequency 
of protective behavior undertaking was significantly associated with respondents’ beliefs about 
the efficacy of the protective measures. (Table 10 to Table 15) present the results of the Chi-
square tests. 
 
The Association between the Frequency of Protective Behavior Undertaking and Self-Efficacy 
Beliefs: 
 
The results of the Chi-square tests indicated that there was a significant association between the 
reported frequency of protective behaviors undertaking and respondents’ beliefs about their 
ability to carry-out those behaviors. This result was observed for all the six protective behavior 
items in the survey. (Table 16 to Table 21) summarize the results of the Chi-square tests. 
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DISCUSSION 
 
 
Knowledge assessment has revealed several patterns in participants’ misconceptions about Zika 
infection. One of these patterns was in the items related to the transmission of the infection. For 
instance, a large proportion of the respondents didn’t recognize the possibility of acquiring the 
infection through sexual contact and via infected blood, while identifying the vector-borne 
transmission route. A possible explanation for this might be related to the finding that media 
platforms constituted the primary source of respondents’ information. Previous research has 
found that most media reports about Zika didn’t address the non-vector-borne routes of 
transmission  [79, 80]. Another topic that was found to be excluded from discussion in the media 
was the treatment of Zika symptoms, and our results revealed significant misconceptions in that 
area as well [80]. Also, media coverage was mostly focused on the negative consequences of 
Zika infection during pregnancy [80]. This might help in explaining our finding that a large 
proportion of participants didn’t recognize the possibility of acquiring the infection and 
developing complications in other age groups and in males. 
Another potential example for the effect of information sources on respondents’ knowledge is 
the significantly higher knowledge scores for participants with college education when compared 
to participants with no college degrees. In contrast to other participants who reported media 
platforms as their primary information source, healthcare professionals were the most frequently 
reported source of information for respondents with college education. However, the higher 
knowledge scores for older participants and participants with no pregnant women in the 
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household cannot be accounted for by the variance in information sources. A possible factor that 
might help explaining the knowledge differences in these demographic groups could be the 
socioeconomic status. Previous research has found a significant impact for participants’ 
socioeconomic status on their knowledge about other diseases [81, 82].  
 Attitudes toward protective behaviors are influenced by attitude-relevant knowledge [83]. 
 A large proportion of respondents in our study didn’t identify sexual transmission as a route of 
contracting Zika infection. Similarly, negative attitudes toward sexual protection measures were 
observed among a large proportion of participants. 
According to the Protection Motivation Theory (PMT), several cognitive processes mediate the 
intention to follow a proposed protective behavior against a threat. These include: the perception 
of the seriousness or severity of the threat, the perception of personal susceptibility to that threat, 
the beliefs about the efficacy of the proposed behavior in neutralizing the threat, and self-
efficacy beliefs, the extent to which a person believes that she/he can competently undertake the 
behavior [84, 85]. This theory has been extensively used as a framework to understand the 
determinants of protective health behavior. Meta-analyses of studies measuring PMT 
components have revealed that all the components had significant effects on health behavior 
intentions and undertaking [86, 87]. In this study, we found that the perceptions of susceptibility 
to Zika infection, beliefs about the efficacy of the proposed behaviors and self-efficacy beliefs 
were associated with significant differences in the frequency of protective behavior undertaking. 
Because the survey was administered in the second half of 2017, we chose to assess the 
frequency of undertaking of the protective behaviors rather than the intentions to engage in these 
behaviors. 
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Some limitations should be taken into account when interpreting the results of this research. For 
instance, the method utilized for recruiting participants might have limited the representativeness 
of the study sample to the general population of South Florida. To minimize the effect of the 
sampling approach, we used quotas to ensure that the sample included participants of different 
age groups, genders, and educational levels. 
Another limitation of this study is the statistical analysis approach. While the statistical tests we 
used (t-Tests, Chi-square, ANOVA) can assess whether a significant association was present 
between two variables, they do not assess the strength of that relationship. Moreover, this 
approach tests the effect of each independent variable on the dependent variable separately, 
without considering the possible interaction between the multiple independent variables.  
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CONCLUSION 
 
 
The findings of this study suggest that more risk communication efforts are needed to increase 
South Floridians' awareness about Zika's public health threat. Also, we identified some 
demographic groups that would benefit from Zika awareness campaigns. Besides, the 
identification of participants' preferred information sources and the factors that were associated 
with more frequent adoption of the protective behaviors can aid in selecting the key risk 
communication messages as well as in choosing the channels to deliver these messages. 
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Figure 1:  Respondents’ age 
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Figure 2 : Respondent’s levels of education 
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Figure 3 : Respondent groups based on the presence of pregnant women in the household 
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Figure 4 : Respondent groups based on the presence of women of childbearing age (15-45) in the household 
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Figure 5 : : Respondents’ answers to the question “Who can get infected with Zika?” 
  Green portions represent the percentages of participants with correct answers 
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Figure 6 : Respondents’ answers to the question “How does a person get infected with Zika ?” 
Green portions indicate the percentages of respondents with correct answers 
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Figure 7 : Respondents’ answers to the question regarding Zika infection symptoms. 
 The green portion represents the percentage of participants with correct answers 
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Figure 8 : Respondents’ answers to the questions regarding the treatment of Zika infections 
 Green portions indicate the percentages of respondents with correct answers 
 
  
36 
 
 
 
Figure 9 : Respondents’ answers to the question regarding Microcephaly 
 The green portion represents the percentage of participants with correct answers 
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Figure 10 : Respondents’ answers to the question regarding GBS 
 The green portion represents the percentage of participants with correct answers 
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Figure 11 : Respondents’ answers to the question regarding Zika vaccine availability 
The green portion represents the percentage of participants with correct answers 
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Figure 12 : Respondents’ answers to the question “On a scale from 1 to 10, how serious would it be for you to contract  
the following disease(s) in the following year?”  
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Figure 13 : Respondents’ answers to the question “"Suppose that you haven't taken any protective measures against Zika . 
On a scale from 1 to 10,What do you think your chance of contracting the infection in the coming year is? 
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Figure 14 : Distributions of Respondents’ reported frequencies of protective behavior undertaking 
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Figure 15 : Responses to the statement “I believe that the following measure(s) can effectively protect against Zika infection:” 
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Figure 16 : Responses to the statement “If recommended by the Centers for Disease Control, I'm confident that I will be able to take  
the following measure(s):” 
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Figure 17 : Reported sources of information about Zika for different age groups 
 
 
  
45 
 
 
Figure 18 : Reported sources of information about Zika categorized by participants’ education levels 
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Figure 19 : Reported sources of information about Zika for different genders 
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Figure 20 : Respondents’ answers to the question “Regarding the current Zika outbreak, what are the most important topics  
about which you want to receive information at this time?” 
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Table 1 : Proportions of Participants with misconceptions about Zika 
  
RESPONDENTS WITH 
MISCONCEPTION(S)* 
 
PROPORTION 
 
 
Lower 
95% CL 
 
Lower 
95% CL 
 
 
Risk groups 358 0.716 0.675 0.754 
Routes of 
transmission 436 0.872 0.840 0.898 
 
Symptoms 103 0.206 0.173 0.244 
Treatment 
(Antibiotic use) 209 0.418 0.376 0.462 
Treatment 
(NSAIDS use) 339 0.678 0.636 0.717 
Complications 
(Microcephaly) 64 0.128 0.102 0.160 
Complications 
(Guillain-Barre 
syndrome) 
171 0.342 0.302 0.385 
Vaccination 
availability 197 0.394 0.352 0.437 
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Table 2 : Analysis of Variance Table for Knowledge score by Age group 
Term Sum of Squares Degrees of 
Freedom 
F p 
Age group 31.01 2 15.35 < .001 
Residuals 501.99 497     
 
 
Table 3 : Means, Standard Deviations, and Sample Size for Knowledge score by Age group 
AGE GROUP M SD n 
18-38 3.79 1.05 244 
39-58 4.29 0.95 141 
59-78 4.3 0.97 115 
 
 
Table 4 : Independent Samples t-Test for the Difference in knowledge scores between Genders 
  MALES  FEMALES   
  
Variable M SD M SD t p d 
Knowledge score 3.97 1.09 4.13 0.97 -1.67 .095 0.15 
Note. Degrees of Freedom for the t-statistic = 491.93. d represents Cohen's d. 
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Table 5 : Independent Samples t-Test for the Difference in Knowledge score by levels of education 
 OTHER 
PARTICIPANTS 
PARTICIPANTS 
WITH COLLEGE 
DEGREES 
 
 
 
Variable M SD M SD t p d 
Knowledge score 3.86 1.08 4.16 0.99 - 3.19 .001 0.29 
Note. Degrees of Freedom for the t-statistic = 498. d represents Cohen's d. 
 
 
Table 6 : Independent Samples t-Test for the difference in knowledge scores by the presence of women 
 of childbearing age in the household 
 Women of childbearing age in the 
household? 
 
NO YES 
Variable M SD M SD t p d 
Knowledge score 4.08 1.11 4.03 0.98 0.52 .606 0.05 
Note. Degrees of Freedom for the t-statistic = 498. d represents Cohen's d. 
 
 
Table 7 : Independent Samples t-Test for the difference in knowledge scores by the presence of pregnant 
 women in the household 
 Pregnant women living in the 
 Household? 
 
NO YES 
Variable M SD M SD t p d 
Knowledge score 4.11 1.03 3.55 0.91 3.69 < .001 0.57 
Note. Degrees of Freedom for the t-statistic = 498. d represents Cohen's d. 
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Table 8 : Independent Samples t-Tests for the association between the frequency of protective behavior undertaking 
and respondents’ perception of Zika infection severity 
 FREQUENTLY 
UNDERTOOK THE 
PROTECTIVE 
BEHAVIOR? 
 
 
NO 
 
YES 
 
VARIABLE 
 
M 
 
SD 
 
M 
 
SD 
 
t 
 
p 
 
d 
 
TEST USED 
 
 
USING MOSQUITO 
REPELLENTS 
 
 
6.30 
 
 
3.17 
 
 
6.49 
 
 
3.13 
 
 
-0.67 
 
 
.503 
 
 
0.06 
 
 
Student’s t-Test 
 
 
WEARING LONG-
SLEEVED 
CLOTHES 
 
 
6.41 
 
 
3.10 
 
 
6.28 
 
 
3.28 
 
 
0.43 
 
 
.665 
 
 
0.04 
 
 
Student’s t-Test 
 
 
 
CONDOM USE 
 
 
6.36 
 
 
3.17 
 
 
6.41 
 
 
3.12 
 
 
-0.18 
 
 
.855 
 
 
0.02 
 
 
Student’s t-Test 
 
 
 
SEXUAL 
ABSTINENCE 
 
 
6.48 
 
 
3.14 
 
 
6.06 
 
 
3.18 
 
 
1.28 
 
 
.202 
 
 
0.13 
 
 
Student’s t-Test 
 
 
REMOVING 
STAGNANT 
WATER 
FROM 
SURROUNDINGS 
 
 
6.07 
 
 
3.17 
 
 
6.60 
 
 
3.12 
 
 
-1.86 
 
 
.063 
 
 
0.17 
 
 
Student’s t-Test 
 
AVOIDING 
TRAVELLING TO 
AREAS WITH 
REPORTED 
INFECTION CASES 
 
 
6.05 
 
 
3.18 
 
 
6.59 
 
 
3.12 
 
 
-1.89 
 
 
.059 
 
 
0.17 
 
 
Student’s t-Test 
 
Note. d represents Cohen's d. 
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Table 9 : Independent Samples t-Tests for the association between the frequency of protective behavior undertaking 
and respondents’ perception of personal susceptibility to Zika infection 
 FREQUENTLY 
UNDERTOOK THE 
PROTECTIVE 
BEHAVIOR? 
 
 
NO 
 
YES 
 
VARIABLE 
 
M 
 
SD 
 
M 
 
SD 
 
t 
 
p 
 
d 
 
TEST USED 
 
 
USING MOSQUITO 
REPELLENTS 
 
 
3.81 
 
 
2.29 
 
 
4.34 
 
 
2.56 
 
 
-2.34 
 
 
.020 
 
 
0.22 
 
 
Welch's t-test 
 
 
WEARING LONG-
SLEEVED 
CLOTHES 
 
 
3.86 
 
 
2.31 
 
 
4.38 
 
 
2.61 
 
 
-2.06 
 
 
.040 
 
 
0.21 
 
 
Welch's t-test 
 
 
CONDOM USE 
 
 
3.76 
 
 
2.26 
 
 
4.59 
 
 
2.64 
 
 
-3.39 
 
 
<.001 
 
 
0.34 
 
 
Welch's t-test 
 
 
SEXUAL 
ABSTINENCE 
 
 
3.88 
 
 
2.32 
 
 
4.39 
 
 
2.63 
 
 
-2.04 
 
 
.042 
 
 
0.21 
 
 
Student’s t-Test 
 
 
REMOVING 
STAGNANT 
WATER 
FROM 
SURROUNDINGS 
 
 
3.66 
 
 
2.18 
 
 
4.27 
 
 
2.55 
 
 
-2.88 
 
 
.004 
 
 
0.26 
 
 
Welch's t-test 
AVOIDING 
TRAVELLING TO 
AREAS WITH 
REPORTED 
INFECTION CASES 
 
 
3.93 
 
 
2.37 
 
 
4.06 
 
 
2.44 
 
 
-0.63 
 
 
.531 
 
 
0.06 
 
 
Student’s t-Test 
 
Note. d represents Cohen's d. 
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Table 10 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for 
(Using mosquito repellents/mosquito nets) 
 Believe that the behavior can be effective? 
Frequently Undertook the 
behavior? 
No Yes 
No 107 [80] 203 [230] 
Yes 22 [49] 168 [141] 
Note. Χ2(1) = 32.37, p < .001. Items in brackets represent expected cell frequencies. 
 
 
Table 11 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for 
(Wearing long-sleeved clothes) 
Frequently Undertook the 
behavior? 
Believe that the behavior can be effective? 
 No Yes 
No 141 [120] 215 [236] 
Yes 27 [48] 117 [95] 
Note. Χ2(1) = 19.99, p < .001. Items in brackets represent expected cell frequencies. 
 
Table 12 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for 
(Condom use) 
 Believe that the behavior can be effective? 
Frequently Undertook the 
behavior? 
No Yes 
No 266 [234] 84 [116] 
Yes 68 [100] 82 [50] 
Note. Χ2(1) = 44.53, p < .001. Items in brackets represent expected cell frequencies. 
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Table 13 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for 
(Sexual abstinence) 
 Believe that the behavior can be effective? 
Frequently Undertook the 
behavior? 
No Yes 
No 304 [270] 74 [108] 
Yes 53 [87] 69 [35] 
Note. Χ2(1) = 61.77, p < .001. Items in brackets represent expected cell frequencies. 
 
 
Table 14 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for 
(Removing stagnant water from surroundings/Covering water containers) 
 Believe that the behavior can be effective? 
Frequently Undertook the 
behavior? 
No Yes 
No 81 [46] 135 [170] 
Yes 25 [60] 259 [224] 
Note. Χ2(1) = 60.48, p < .001. Items in brackets represent expected cell frequencies. 
 
Table 15 : Chi-Square test of association between the frequency of undertaking and response efficacy beliefs for 
(Avoiding travel to areas where infection cases were reported) 
 Believe that the behavior can be effective? 
Frequently Undertook the 
behavior? 
No Yes 
No 63 [36] 141 [168] 
Yes 25 [52] 271 [244] 
Note. Χ2(1) = 41.92, p < .001. Items in brackets represent expected cell frequencies.  
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Table 16 : Chi-Square test of association between the frequency of undertaking and self- efficacy beliefs for (Using 
mosquito repellents/mosquito nets) 
 Believes in his/her ability to undertake that behavior? 
Frequently Undertook the 
behavior? 
No Yes 
No 76 [57] 234 [253] 
Yes 16 [35] 174 [155] 
Note. Χ2(1) = 20.32, p < .001. Items in brackets represent expected cell frequencies. 
 
 
Table 17 : Chi-Square test of association between the frequency of undertaking and self- efficacy beliefs for 
(Wearing long-sleeved clothes) 
 Believes in his/her ability to undertake that behavior? 
Frequently Undertook the 
behavior? 
No Yes 
No 109 [87] 247 [269] 
Yes 13 [35] 131 [109] 
Note. Χ2(1) = 25.91, p < .001. Items in brackets represent expected cell frequencies. 
 
Table 18 : Chi-Square test of association between the frequency of undertaking and self- efficacy beliefs for 
(Condom use) 
 Believes in his/her ability to undertake that behavior? 
Frequently Undertook the 
behavior? 
No Yes 
No 246 [193] 104 [158] 
Yes 29 [83] 121 [68] 
Note. Χ2(1) = 110.14, p < .001. Items in brackets represent expected cell frequencies.  
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Table 19 : Chi-Square test of association between the frequency of undertaking and self-efficacy beliefs for (Sexual 
abstinence) 
 Believes in his/her ability to undertake that behavior? 
Frequently Undertook the 
behavior? 
No Yes 
No 309 [262] 69 [115.67] 
Yes 38 [84.67] 84 [37] 
Note. Χ2(1) = 111.19, p < .001. Items in brackets represent expected cell frequencies. 
 
 
Table 20 : Chi-Square test of association between the frequency of undertaking and self-efficacy beliefs for 
(Removing stagnant water from surroundings/Covering water containers) 
 Believes in his/her ability to undertake that behavior? 
Frequently Undertook the 
behavior? 
No Yes 
No 64 [36] 152 [180] 
Yes 20 [48] 264 [236] 
Note. Χ2(1) = 44.78, p < .001. Items in brackets represent expected cell frequencies. 
 
Table 21 : : Chi-Square test of association between the frequency of undertaking and self-efficacy beliefs for 
(Avoiding travel to areas where infection cases were reported) 
 Believes in his/her ability to undertake that behavior? 
Frequently Undertook the 
behavior? 
No Yes 
No 64 [33] 140 [171] 
Yes 16 [47] 280 [249] 
Note. Χ2(1) = 60.59, p < .001. Items in brackets represent expected cell frequencies.  
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